vimarsana.com
Home
Live Updates
ImmuCell Receives Technical Section Incomplete Letter from :
ImmuCell Receives Technical Section Incomplete Letter from :
ImmuCell Receives Technical Section Incomplete Letter from
PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...
Related Keywords
Maine ,
United States ,
Russia ,
Ukraine ,
Joe Dorame ,
Robert Blum ,
Michaelf Brigham ,
Joe Diaz ,
Exchange Commission ,
Lytham Partners ,
Immucell Corporation Nasdaq ,
Securities Exchange ,
Immucell Corporation ,
Cell Corporation ,
Technical Section Incomplete Letter ,
New Animal Drug Application ,
Technical Section ,
Quarterly Report ,
Immediate Immunity ,
Note Regarding Forward Looking Statements ,
Press Release ,
Securities Act ,
Securities Exchange Act ,
Good Manufacturing Practice ,
Nisin Drug Substance ,
Drug Product ,
Quarterly Reports ,
Annual Reports ,
Current Reports ,
Nasdaq Iccc ,